Microplastics are ‘far from benign' — here's how they can devastate your immune system
Well, this blows.
Microplastics — pesky particles that have contaminated our air, water, food and bodies — have been linked to a higher risk of inflammation, hormone disruption, DNA damage, respiratory illnesses and heart problems, among other health issues.
A new study suggests that inhaling microplastics can suppress a type of white blood cell in the lungs that's essential to the immune system, raising the risk of cancer and other diseases.
Advertisement
3 Microplastics — pesky particles that have contaminated our air, water, food and bodies — have been linked to a range of health issues. A new study reveals how they can harm our immune system.
SIV Stock Studio – stock.adobe.com
'For me, it's a bit eye-opening that although microplastics aren't the most dangerous agent we may encounter, they are far from benign,' said first study author Adam Soloff, an associate professor of cardiothoracic surgery at the University of Pittsburgh.
Microplastics are smaller than a pencil eraser. They slough off polyester clothing, car tires and plastic bottles and bags. Some are intentionally manufactured for personal care products, like microbeads found in exfoliating scrubs, facial cleansers and toothpastes.
Advertisement
For the new study, Soloff's team had mice inhale microplastics to measure the effects on their body.
The minute plastic fragments were detected in their liver, spleen and colon. Trace amounts were found in their brain and kidneys for up to a week after they breathed them in.
'Respiratory microplastics disseminate systemically after passing through the lung,' Soloff explained. 'Overall, these may have detrimental effects on any and all organ systems and contribute to a number of diseases.'
3 'It's a bit eye-opening that although microplastics aren't the most dangerous agent we may encounter, they are far from benign,' said first study author Adam Soloff (pictured here).
Adam Soloff
Advertisement
The researchers also cultured macrophages with different sizes of polystyrene microplastics. Styrofoam packaging, disposable coffee cups and foam are made from polystyrene.
Macrophages are the most abundant immune cells in the lungs. They are vital in removing damaged cells and debris, resolving inflammation and promoting tissue repair.
Within 24 hours, the macrophages labored to engulf and digest bacteria, a critical cell process known as phagocytosis.
Advertisement
'When we first started to discuss these microplastic exposures, I was sure that the macrophages would just eat (phagocytose) and digest them (lysosomally process), and that would be the end of it,' Soloff said.
'I was really surprised to see that not only did the macrophages struggle to break down the plastics in vitro, but macrophages in the lung retained these particles over time as well.'
3 This diagram from the study shows how microplastics affect the function of macrophages.
ATS Journals
The good news is that researchers found that Acadesine, a drug primarily used to treat acute lymphoblastic leukemia, restored some macrophage function.
The results were presented Monday at the American Thoracic Society conference in San Francisco.
Soloff's team plans to examine microplastic exposure in lung tissues to develop an early warning system for lung disease and lung cancer risk.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
16 hours ago
- New York Post
Glass bottles found to have five to 50 times as many microplastics as plastic bottles in shocking new study
Looks like the glass is half full…of plastic. Microplastics are everywhere — in your chewing gum, your beauty products and even your favorite junk food. Given the name, it's reasonable to assume you're more likely to find them in products containing plastic than not. Advertisement 3 Microplastics are everywhere — in your chewing gum, your beauty products and even your favorite junk food. SIV Stock Studio – But a jaw-dropping new study — published in the Journal of Food Composition and Analysis — has discovered quite the opposite seems to be the case. Guillaume Duflos, research director at French food safety watchdog ANSES, told AFP that his team set out to 'investigate the quantity of microplastics in different types of drinks sold in France and examine the impact different containers can have.' Advertisement Much to their surprise, they found that glass-bottled beverages — including lemonade, iced tea, beer and soda — had five to 50 times more microplastics than their plastic or metal counterparts. Needless to say, the team 'expected the opposite result,' study co-author Iseline Chaib told AFP. Researchers found an average of roughly 100 microplastic particles per liter in these glass bottles, which they pinned on the paint on their caps. 3 Glass-bottled beverages had five to 50 times more microplastics than their plastic or metal counterparts. SKfoto – Advertisement 'We…noticed that in the glass, the particles emerging from the samples were the same shape, color and polymer composition — so, therefore, the same plastic — as the paint on the outside of the caps that seal the glass bottles,' Chaib said. They theorized that 'tiny scratches, invisible to the naked eye, probably due to friction between the caps when there were stored,' might subsequently 'release particles onto the surface of the caps.' Still, some of the study's findings remain a mystery. 3 Bottles of wine contained very few microplastics, even when capped. Gary Perkin – Advertisement The team found only 4.5 particles and 1.6 particles of microplastics per liter in glass and plastic bottles, respectively. And — in more good news — bottles of wine also contained very few microplastics, even when capped. In contrast, there were 60, 40 and 30 microplastics per liter in beer, lemonade and soft drinks, respectively. Duflos admitted that the reason behind this inconsistency 'remains to be explained.' While the full health impact of microplastics continues to be unclear, studies have linked them to inflammation, hormone disruption, DNA damage, respiratory illnesses, heart problems and certain cancers. ANSES suggests a quick fix: try blowing on the caps and rinsing them with water and alcohol. The French watchdog found this method can slash plastic contamination by 60 percent.
Miami Herald
7 days ago
- Miami Herald
mRNA vaccine technology makes headway via Pitt, Penn State research
A new kind of mRNA vaccine developed by researchers at the University of Pittsburgh and Penn State University could be cheaper to produce and offer a greater level of immunity across multiple variants of the virus. The news comes as mRNA vaccines have been targeted by the Trump administration's recent funding cuts, and Health Secretary Robert F. Kennedy Jr. fired all members of the expert vaccine panel the Advisory Committee on Immunization Practices, which advises the Centers for Disease Control and Prevention on vaccine safety and eligibility guidelines. Results of the Pitt study, tested in a small group of mice, were published in npj Vaccines, a journal associated with Nature, on June 3. It's considered a proof-of-concept study and will require more research until human clinical trials are possible. Continual mutation of the SARS-CoV-2 virus - the virus that causes COVID-19 - has presented challenges for scientists' ability to forecast a dominant variant and tailor vaccines effectively, requiring recalibration each year depending on what is currently circulating. "This study demonstrated two key aspects," said Suresh Kuchipudi, senior author on the paper and chair of infectious diseases and microbiology at Pitt's School of Public Health, "that we can produce mRNA vaccines with much less mRNA required, that will significantly lower the cost of the vaccines." And, he said, "It is also possible that with mRNA vaccines, we can provide broad protection across multiple versions of the virus without needing to constantly update." This was possible because of a design called a trans-amplifying vaccine. In traditional mRNA vaccines, a single molecule of RNA - a kind of code that creates viral proteins in the body - is included to help the body recognize and fight off viruses. Amplifying RNA vaccines use two components: that viral protein, as well as another component that helps enhance the mRNA signal. In trans-amplifying mRNA vaccines, those two components are encoded separately, allowing for more flexibility in design and potentially fewer side effects, though the latter needs further study. And instead of using code from one circulating variant, the trans-amplifying vaccine uses code from a "consensus spike protein," meaning it includes mRNA that is conserved across multiple variants, allowing it to provide broader immunity. "After several years, we have seen multiple variants emerge," said Kuchipudi. "If you look at the genetic sequence of the spike protein among all these variants, certain parts are conserved across all. We can design a spike protein that can broadly cover known variants." The new formulation also includes a component called a replicase, which helps to generate a signal in the body with a lower dose of mRNA. Researchers used a replicase based on the Venezuelan Equine Encephalitis Virus (VEEV). "We chose the VEEV replicase because it's a well-studied enzyme known for its ability to amplify target mRNA efficiently," said Kuchipudi in an email. "In our system, it boosts the expression of the vaccine antigen (SARS-CoV-2) without requiring a high starting dose." They also conducted safety studies and found the VEEV replicase did not affect the body's original cells in a negative way. Scientists then measured the presence of antibodies in the injected mice to see how their new vaccine formulation compared to the traditional mRNA vaccine. The mice showed immunity comparable to the original COVID-19 mRNA vaccines and with 40 times less mRNA used. Moderna's current Spikevax formulation is given at 50 micrograms per dose for adults, and Pfizer/BioNTech's Comirnaty contains 30 micrograms (ug) per dose. This could be why many people who received the Moderna vaccine reported more side effects. The trans-amplifying vaccine, by contrast, was given at 20 ug of the VEEV replicase and 0.5 ug of the consensus spike protein mRNA, as well as a lower dose formulation at 20 ugs and 0.05 ugs, respectively. This vaccine could offer greater flexibility and be more cost efficient than the existing COVID vaccines, said Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and co-director of the Texas Children's Hospital Center for Vaccine Development. "I think it's a worthwhile study," he said. The study is also an example of how much research goes into a product like a vaccine before it becomes available to the public - and this one is still early in the developmental process. Kuchipudi said the team wants to delve deeper into learning more about potential side effects. "We did some early mouse studies and saw no apparent side effects," said Kuchipudi. "We plan to conduct more in-depth safety studies in mice next, focusing on immune responses, inflammation, and any potential off-target effects," or unpredictable side effects that might occur other than at the injection site, or what's typically associated with getting a vaccine. But in the current political climate, it may be harder for scientists to further their research on these kinds of vaccines. On May 28, President Trump rescinded its contract with Moderna, per Reuters reporting. That included more than $700 million in federal monies for vaccine research and development for diseases like bird flu. In a statement to Reuters, an HHS spokesperson said that "after a comprehensive internal review, the agency had determined that the project did not meet the scientific standards or safety expectations required for continued federal investment." Although mRNA vaccines have been around since the 1990s, they have been the face of intense scrutiny after their development was fast-tracked via Operation Warp Speed, the government-backed push to get COVID-19 vaccines into the hands of the public during a deadly pandemic. To date, they have saved 3.2 million lives, said Hotez. "What you should be focusing on, if there are ways you think you can improve the technology, that's what you have to incentivize," he said. The Pitt and Penn State study is illustrative of that, he said. "This is an example of heading toward 2.0." But Hotez is worried about deprioritization of this kind of research in the coming years, especially as infectious disease surveillance infrastructure, including staffing, has been cut, leaving officials in a weaker position to understand and defend against future viruses. "I think the FDA is prematurely shutting down mRNA technology when it has enormous promise," he said. "It's a relatively safe vaccine. Every vaccine technology has strengths and weaknesses ... to toss it out the window for ideological reasons makes no sense." _____ Copyright (C) 2025, Tribune Content Agency, LLC. Portions copyrighted by the respective providers.
Yahoo
15-06-2025
- Yahoo
Electrons spiral with a purpose: A new platform decodes their selective spin
By combining the principles of physics, chemistry, and biology, scientists have crafted a special programmable platform to explore one of the most puzzling quantum mysteries of our time: why electrons seem to choose sides when passing through certain twisted molecules. This behavior, known as the chiral-induced spin selectivity (CISS) effect, has baffled researchers for over two decades. It shows up in biological processes like photosynthesis and cellular respiration, yet no one fully understands how or why it happens. Now, researchers from the University of Pittsburgh have engineered an artificial, controllable system that can mimic the conditions under which this strange effect occurs. Their approach could reshape how we study quantum transport and might also help us design new materials for electronics, energy, and even medicine. "The beauty of our approach is not that it mimics chemistry or biology exactly, but that it allows us to isolate and study individual processes that are relevant in chiral quantum transport," said François Damanet, a physicist and one of the members of the research team. Back in the late 1990s, scientists Ron Naaman and David Waldeck made a surprising discovery. When electrons pass through films of chiral (twisted) molecules, how easily they can move is decided by their spin, which is a quantum property. Instead of a small noticeable effect, they saw spin-dependent changes as high as 20 percent, a result that stunned the scientific community. Since then, the CISS effect has popped up in various biological systems, yet researchers haven't been able to pin down the exact mechanism behind it. This is because real biological molecules are complex. They're soft, flexible, constantly moving, and surrounded by water, all of which makes it nearly impossible to isolate the role of chirality alone. That's where the new platform comes in. The researchers did not try to recreate biology. Instead, they built a clean, programmable playground for electrons. Using a technique developed in 2008, they worked with a special material made from layers of lanthanum aluminate (LaAlO3) and strontium titanate (SrTiO3). By using a fine-tipped microscopic pen, they could draw paths where electrons can travel. To make those paths chiral, they introduced a clever twist: the probe not only moved in a wavy, serpentine pattern across the surface, but its voltage was also modulated up and down in sync. This combination created spiral-like channels that broke mirror symmetry, the key ingredient of chirality. These artificial chiral waveguides weren't just pretty shapes. When electrons flowed through them, surprising quantum effects emerged. The team saw unusual conductance patterns and even observed electrons pairing up in ways that shouldn't be possible under strong magnetic fields. Theoretical models suggested that the spiral geometry created a kind of engineered spin-orbit coupling, which locked the electrons' spin to their direction of motion, just like some theories had proposed for the CISS effect in molecules. What makes this platform so powerful is that it's fully programmable. Researchers can change the shape, size, and strength of the chiral patterns, erase them, and write new ones, all on the same device. "We can systematically vary parameters like the pitch, amplitude, and coupling strength of chiral modulations—something impossible with fixed structures," Damanet said. This new platform doesn't try to copy molecules atom-for-atom. Instead, it gives scientists something they've never had before: precise control. In biological systems, everything is messy—molecules wiggle, environments shift, and vibrations interfere with measurements. However, on this programmable platform, each variable can be changed independently, allowing researchers to test exactly how chirality affects quantum transport. This could help settle long-standing debates about whether spin-orbit interactions, molecular vibrations, or other mechanisms drive the CISS effect. While the system operates at ultra-cold temperatures and uses inorganic materials, it sets the stage for future hybrid setups that could combine these solid-state tools with real molecules. The team is already exploring ways to pair their platform with organic materials or carbon nanotubes, and even to run experiments at higher temperatures. The goal isn't to replace biological studies, but to work alongside them, much like how wind tunnels help engineers test aircraft designs before real-world flights. If successful, this approach could help scientists not only solve the CISS puzzle but also understand other complex quantum systems. It could inspire new materials for spintronics, where electron spin is used in computing, or guide the design of efficient catalysts and bio-inspired energy devices. The study is published in the journal Science Advances.
